Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-007482

Options or other derivatives

  • CEO acquired 464,907 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Shah Gaurav CEO 2023-02-14 Grant or award · Stock Option (Right to Buy) +348,590 348,590 D
Shah Gaurav CEO 2023-02-14 Grant or award · Restricted Stock Units +116,317 116,317 D
Loading xslF345X03/form4.xml…